Key result
Combined echocardiography and tissue Doppler imaging can identify mutation carriers in familial hypertrophic cardiomyopathy prior to the development of hypertrophy.
Why the study?
Does combined echocardiography, tissue Doppler imaging, and ECG identify mutation carriers in familial hypertrophic cardiomyopathy before the development of hypertrophy?
Does combined echocardiography, tissue Doppler imaging, and ECG identify mutation carriers in familial hypertrophic cardiomyopathy before the development of hypertrophy?
Combined echocardiography, tissue Doppler imaging, and ECG are being evaluated for their ability to identify mutation carriers in familial hypertrophic cardiomyopathy prior to the onset of overt hypertrophy.
Answers are grounded in this paper and cite their sources.
May support preclinical screening in familial HCM families; leaves open prospective validation before practice change.
AimsPreliminary studies suggested that tissue Doppler imaging (TDI) was able to identify mutation carriers in familial hypertrophic cardiomyopathy (HCM) before the development of hypertrophy. However, data are limited. We performed a systematic analysis of echocardiography, TDI, and electrocardiogram (ECG) in familial HCM to identify parameters associated with genetic status.
No takes yet. Share an insight, caveat, or question.
Gandjbakhch et al. (2010) studied this question. Combined echocardiography and tissue Doppler imaging can identify mutation carriers in familial hypertrophic cardiomyopathy prior to the development of hypertrophy.
Synapse has enriched 10 related papers. Consider them for comparative context: